However, recent data have shown that the low sensitivity and specificity are challenges in the diagnosis of HCC25, especially for early stage HCC, as the sensitivity of combined serum AFP and ultrasonography only varies from 40 to 65%26. This evidence concerns the gene AFP and hepatocellular carcinoma.